RecruitingNot ApplicableNCT07529119

Effect of Consuming a Mango and Chia-based Beverage on Modulating the Intestinal Microbiota in Obese Children


Sponsor

Universidad Nacional de Caaguazu

Enrollment

100 participants

Start Date

Feb 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 6 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.


Eligibility

Min Age: 8 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Mango and chia juice and Mango juice for people with microbiota. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years to 16 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMango juice

Mango juice drink for 6 weeks 200 ml daily, 5 days a week

OTHERMango and chia juice

Mango and chia juice drink for 6 weeks, 200 ml daily 5 days a week


Locations(1)

UNCA

Coronel Oviedo, Paraguay

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07529119


Related Trials